跳至正文
研究论文

Human papillomavirus infection as a prognostic marker for lung adenocarcinoma: a systematic review and meta-analysis.

Guo Lanwei, Liu Shuzheng, Zhang Shaokai, Chen Qiong, Zhang Meng, Quan Peiliang, Sun Xibin · 共同作者

Oncotarget2017; 8(21): 34507--34515

DOI
10.18632/oncotarget.15671
PMID
28427144

摘要

关键词 · HPV, lung cancer, meta-analysis, prognosis

Although a number of studies have investigated the association between human papillomavirus (HPV) and lung cancer prognosis, the results remain inconsistent. We therefore conducted a meta-analysis of epidemiologic studies to address this issue. Searches of the MEDLINE and EMBASE electronic databases from their inception until June 30, 2016 yielded nine studies involving a total of 1,205 lung cancer cases that were used to conduct the meta-analysis. Study-specific risk estimates were pooled using a random-effects model. The pooled hazard ratio (HR) comparing HPV-positive to HPV-negative cancers 1.00 (95% confidence interval (CI): 0.78-1.28) was not significantly correlated with overall survival. However, lung adenocarcinoma patients with HPV infections exhibited a survival benefit compared to those without HPV infection (HR=0.69, 95% CI: 0.50-0.96). This meta-analysis suggests HPV infection is a prognostic marker in lung adenocarcinoma. To further elucidate the epidemiology and pathogenesis of HPV infections in lung cancer, future large prospective studies are encouraged to stratify survival analysis based on the pathological type and clinical stage of the cancer.

陈琼发布于 173 字约 1 分钟阅读浏览量加载中…

留言板

欢迎留下与本页内容相关的问题、建议或想法。

正在读取留言…

审核通过后,昵称和留言将公开显示。请勿填写私人联系方式。

← 返回论文列表